TALPHERA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 USD | -0.96% |
|
-4.63% | +40.14% |
| 14/05 | Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.75Cr | - | - | - | - | - | |
| 872.08Cr | ||||||
| 478.98Cr | ||||||
| 462.18Cr | - | - | ||||
| 382.39Cr | ||||||
| 233.24Cr |
- Stock Market
- Equities
- TLPH Stock
- Charts Talphera, Inc.
- Sector Chart
